A61K35/60

COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURY AND SYNAPTIC DYSFUNCTION
20220323440 · 2022-10-13 ·

The present invention provides methods and compositions for treating synaptic dysfunction and spinal cord injuries comprising, for example, the administration of a compound that increases the level of PZP in vivo.

Compositions Comprising Extracellular Matrix of Primitive Animal Species and Related Methods
20220323510 · 2022-10-13 ·

A method is provided for preparing an ECM material, including an ECM gel, from regenerative or regenerating tissue. ECM material prepared from regenerative or regenerating materials also is provided.

Compositions Comprising Extracellular Matrix of Primitive Animal Species and Related Methods
20220323510 · 2022-10-13 ·

A method is provided for preparing an ECM material, including an ECM gel, from regenerative or regenerating tissue. ECM material prepared from regenerative or regenerating materials also is provided.

Methods and compositions for oral administration of proteins
11660327 · 2023-05-30 · ·

This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.

Methods and compositions for oral administration of proteins
11660327 · 2023-05-30 · ·

This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.

Methods and compositions for oral administration of proteins
11660327 · 2023-05-30 · ·

This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.

NUTRITIONAL COMPOSITION
20230113424 · 2023-04-13 ·

The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.

NUTRITIONAL COMPOSITION
20230113424 · 2023-04-13 ·

The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.

NUTRITIONAL COMPOSITION
20230113424 · 2023-04-13 ·

The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.

FATTY ACID COMPOSITIONS FOR ENTERAL USE
20230113738 · 2023-04-13 ·

This disclosure provides an isotonic lipid emulsion for enteral administration comprising Omega-3 fatty acids and medium-chain triglyceride (MCT) fatty acids. The lipid particles administered through the disclosed lipid emulsion can be efficiently absorbed by animal and human body and rapidly enriched on organ and tissue cell membranes.